PH19442A - Beta-lactamase inhibiting 2 beta-substituted 2 alpha-methyl(5r)penam-3 alpha-carboxylic acid 1,1 dioxides and intermediates therefor - Google Patents

Beta-lactamase inhibiting 2 beta-substituted 2 alpha-methyl(5r)penam-3 alpha-carboxylic acid 1,1 dioxides and intermediates therefor

Info

Publication number
PH19442A
PH19442A PH27864A PH27864A PH19442A PH 19442 A PH19442 A PH 19442A PH 27864 A PH27864 A PH 27864A PH 27864 A PH27864 A PH 27864A PH 19442 A PH19442 A PH 19442A
Authority
PH
Philippines
Prior art keywords
beta
alpha
penam
dioxides
substituted
Prior art date
Application number
PH27864A
Other languages
English (en)
Inventor
Wayne Ernest Barth
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH19442A publication Critical patent/PH19442A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PH27864A 1981-09-14 1982-09-13 Beta-lactamase inhibiting 2 beta-substituted 2 alpha-methyl(5r)penam-3 alpha-carboxylic acid 1,1 dioxides and intermediates therefor PH19442A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/301,995 US4356174A (en) 1981-09-14 1981-09-14 Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl-(5R)penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor

Publications (1)

Publication Number Publication Date
PH19442A true PH19442A (en) 1986-04-18

Family

ID=23165806

Family Applications (1)

Application Number Title Priority Date Filing Date
PH27864A PH19442A (en) 1981-09-14 1982-09-13 Beta-lactamase inhibiting 2 beta-substituted 2 alpha-methyl(5r)penam-3 alpha-carboxylic acid 1,1 dioxides and intermediates therefor

Country Status (25)

Country Link
US (1) US4356174A (fi)
EP (1) EP0074783B1 (fi)
JP (1) JPS5859990A (fi)
KR (1) KR860001361B1 (fi)
AT (1) ATE14585T1 (fi)
AU (1) AU532401B2 (fi)
CA (1) CA1212378A (fi)
CS (1) CS236681B2 (fi)
DE (1) DE3265082D1 (fi)
DK (1) DK407882A (fi)
ES (1) ES515649A0 (fi)
FI (1) FI823165L (fi)
GR (1) GR76726B (fi)
HU (1) HU186575B (fi)
IE (1) IE53819B1 (fi)
IL (1) IL66776A (fi)
IN (1) IN159366B (fi)
NO (1) NO823093L (fi)
NZ (1) NZ201895A (fi)
PH (1) PH19442A (fi)
PL (1) PL139272B1 (fi)
PT (1) PT75548B (fi)
SU (1) SU1272995A3 (fi)
YU (1) YU205182A (fi)
ZA (1) ZA826687B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760058A (en) * 1984-08-29 1988-07-26 Farmitalia Carlo Erba S.P.A. Penam derivatives
US4861768A (en) * 1986-02-27 1989-08-29 Taiho Pharmaceutical Company, Limited 2 β-substituted thiomethylpenicillin derivatives and their preparation and use
TW383308B (en) * 1993-08-24 2000-03-01 Hoffmann La Roche 2-beta-alkenyl penam sulfones as beta-lactamase inhibitors
EP0966471B1 (en) * 1997-12-29 2002-06-12 Research Corporation Technologies, Inc 2-beta-substituted-6-alkylidene penicillanic acid derivatives as beta-lactamase inhibitors
US6407091B1 (en) * 1999-04-15 2002-06-18 Research Corporation Technologies, Inc. β-lactamase inhibiting compounds
AU2002353768A1 (en) * 2001-07-24 2003-03-18 Alamx, L.L.C. 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors.
AU2003224874A1 (en) * 2002-04-04 2003-10-27 Alamx, L.L.C. INHIBITORS OF SERINE AND METALLO-ss-LACTAMASES
KR100796131B1 (ko) * 2005-04-06 2008-01-21 후지쯔 가부시끼가이샤 휴대형 전자 기기
CN104650119B (zh) * 2015-02-10 2017-04-05 中国科学院长春应用化学研究所 一种β‑内酰胺化合物的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1541832A (en) * 1976-02-11 1979-03-07 Beecham Group Ltd 2-substituted penam derivatives methods for their preparation and compisitions containing them
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
US4241050A (en) * 1978-09-01 1980-12-23 Pfizer Inc. Penam 1,1-dioxides as beta-lactamase inhibitors
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
US4287181A (en) * 1979-10-22 1981-09-01 Pfizer Inc. Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JPS6153354B2 (fi) 1986-11-17
NZ201895A (en) 1985-03-20
KR840001581A (ko) 1984-05-07
DE3265082D1 (en) 1985-09-05
ES8308566A1 (es) 1983-09-16
DK407882A (da) 1983-03-15
KR860001361B1 (ko) 1986-09-16
SU1272995A3 (ru) 1986-11-23
PL238200A1 (en) 1985-02-13
IN159366B (fi) 1987-05-09
HU186575B (en) 1985-08-28
JPS5859990A (ja) 1983-04-09
ATE14585T1 (de) 1985-08-15
FI823165A0 (fi) 1982-09-13
PT75548A (en) 1982-10-01
CS236681B2 (en) 1985-05-15
CA1212378A (en) 1986-10-07
IE53819B1 (en) 1989-03-01
PT75548B (en) 1985-12-09
EP0074783A1 (en) 1983-03-23
FI823165L (fi) 1983-03-15
IL66776A (en) 1985-07-31
IE822232L (en) 1983-03-14
NO823093L (no) 1983-03-15
US4356174A (en) 1982-10-26
GR76726B (fi) 1984-08-30
EP0074783B1 (en) 1985-07-31
YU205182A (en) 1985-03-20
ZA826687B (en) 1983-07-27
PL139272B1 (en) 1987-01-31
ES515649A0 (es) 1983-09-16
AU8833982A (en) 1983-03-24
AU532401B2 (en) 1983-09-29

Similar Documents

Publication Publication Date Title
DE3689572D1 (de) Verfahren zur Isolierung von Genen zur Biosynthese von Antibiotika.
ES8204437A1 (es) Un procedimiento para la preparacion de acidos 6-b-hidroxialquilpenicilanicos y sus derivados.
PH19442A (en) Beta-lactamase inhibiting 2 beta-substituted 2 alpha-methyl(5r)penam-3 alpha-carboxylic acid 1,1 dioxides and intermediates therefor
DE3853962D1 (de) Verfahren zur Kristallisation von Kalium-Clavulanat.
ES8305769A1 (es) Un procedimiento para la preparacion de bis-esteres de 1,1-alcanodioles.
DE58903966D1 (de) Stabilisierter treibsatz zur erzeugung ungiftiger treibgase.
IE820342L (en) Penicillins
GB2045755B (en) Process and intermediates for penicillanic acid 1,1-dioxide and esters thereof
DE59201910D1 (de) Verfahren zur Herstellung von feuerfesten Chromoxid-Steinen.
FR2711365B1 (fr) Procédé d'hydroxycarbonylation du butadiène.
DE3362826D1 (en) 6-aminoalkylpenicillanic acid 1,1-dioxides and derivatives as beta-lactamase inhibitors
ZA80646B (en) Process and intermediates for penicillanic acid,1,1-dioxide and esters thereof
DE69203707D1 (de) Verfahren zur Reinigung von Fluorethanen und Chlorfluorethanen.
DE3261759D1 (en) Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
AU571370B2 (en) Process for the purification of liquid sulphur
DE69206116D1 (de) Verfahren zur Reinigung von 1,1-Dichlor-1-Fluorethan.
DE69123447D1 (de) Verfahren zur Korrosionsverhützung beim Unsäuern von Quellen